Skip to content
OpenCapital
Get started

X4 Pharmaceuticals XFOR Q3 2025 earnings

Reported November 5, 2025 · Before market open

Revenue$1.8MBeat by $32.0K
EPS-$0.69Beat by $0.10
Revenue estimate$1.7M
EPS estimate-$0.79

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$2.4M
EPS estimate-$0.19

Versus estimates

Revenue

Q1 2026$2.5MMiss by $731.0KQ4 2025$2.6MBeat by $835.0K
Q3 2025$1.8MBeat by $32.0K
Q2 2025$2.0MMiss by $253.4KQ1 2025$28.8MBeat by $26.9MQ4 2024$1.4MMiss by $800.2K

Diluted EPS

Q1 2026-$0.16Beat by $0.04Q4 2025-$0.22Beat by $0.14
Q3 2025-$0.69Beat by $0.10
Q2 2025-$3.47Beat by $1.06Q1 2025$0.04Beat by $4.17Q4 2024-$6.01Miss by $0.90

Ask the moment X4 Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did X4 Pharmaceuticals report Q3 2025 earnings?
X4 Pharmaceuticals (XFOR) reported Q3 2025 earnings on November 5, 2025 before market open.
What were X4 Pharmaceuticals's Q3 2025 revenue and EPS?
X4 Pharmaceuticals reported revenue of $1.8M and eps of $-0.69 for Q3 2025.
Did X4 Pharmaceuticals beat estimates in Q3 2025?
Revenue beat the consensus estimate of $1.7M by $32.0K. EPS beat the consensus estimate of $-0.79 by $0.10.
How did X4 Pharmaceuticals's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 215.2% from $560.0K a year earlier and eps declined 283.3% from $-0.18.
Where can I find X4 Pharmaceuticals's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001501697-25-000041) and the 10-Q periodic report (0001501697-25-000043) directly on SEC EDGAR. The filing index links above go to sec.gov.